Goldman Sachs’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5M | Buy |
|
|||||
|
2025
Q1 | $17.3M | Sell |
|
|||||
|
2024
Q4 | $18.2M | Sell |
|
|||||
|
2024
Q3 | $14.8M | Buy |
|
|||||
|
2024
Q2 | $7.51M | Buy |
|
|||||
|
2024
Q1 | $7.99M | Buy |
|
|||||
|
2023
Q4 | $2.37M | Buy |
|
|||||
|
2023
Q3 | $1.77M | Sell |
|
|||||
|
2023
Q2 | $6.62M | Buy |
|
|||||
|
2023
Q1 | $2.72M | Sell |
|
|||||
|
2022
Q4 | $4.14M | Buy |
|
|||||
|
2022
Q3 | $3.5M | Buy |
|
|||||
|
2022
Q2 | $2.05M | Buy |
|
|||||
|
2022
Q1 | $1.21M | Buy |
|
|||||
|
2021
Q4 | $1M | Buy |
|
|||||
|
2021
Q3 | $971K | Buy |
|
|||||
|
2021
Q2 | $866K | Buy |
|
|||||
|
2021
Q1 | $619K | Sell |
|
|||||
|
2020
Q4 | $6.32M | Buy |
|
|||||
|
2020
Q3 | $5.26M | Buy |
|
|||||
|
2020
Q2 | $5.2M | Sell |
|
|||||
|
2020
Q1 | $5.95M | Buy |
|